Physician Assisted Suicide: A Case Study

220 Words1 Page
Pradaxa is an anticoagulant medication used to reduce the risk of stroke and blood clots in patients with non-valvular atrial fibrillation. In clinical trials conducted, Pradaxa outperformed warfarin, reducing the risk of stroke more effectively than warfarin. However, Pradaxa has been blamed for more than 500 deaths related to hemorrhaging and uncontrollable bleeding. Moreover Pradaxa does not have an antidote to stop bleeding (Southworth, Reichman, & Unger, 2013). Because of these adverse effects the drug manufacturer Boehringer Ingleheim has discovered the antidote drug known as Idarucizumab which is in phase III of clinical trials. The results from Phase III trial showed that Idarucizumab was able to completely reverse the blood thinning

More about Physician Assisted Suicide: A Case Study

Open Document